Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...

Coty Inc. (COTY) posted first-quarter fiscal 2026 results, wherein both top and bottom lines missed the Zacks Consensus Estimate. Both net sales and earnings also experienced year-over-year ...

Explore the best gifts for runners we tested and loved. Browse picks from Lululemon, Athleta, ASICS, Supergoop, and more.

Looking for the best gifts for her? From under-$10 stocking stuffers to splurge-worthy home and kitchen upgrades, our top ...

Hims & Hers Health Inc (NYSE: HIMS) isn't just chasing wellness trends — it's building a global health platform. At the ...

Hims and Hers Health Inc. rose after the telehealth company said it was in talks with Novo Nordisk A/S to sell its ...

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Millions of men undergoing hair ...

Oral vs. Topical Minoxidil: Which Is Better for Hair Loss? Minoxidil is one of the most commonly used hair loss treatments — and for good reason. Simply put, it works. But if you’ve decided on ...

Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof. Mayer Brezis’s review exposes global data showing psychiatric harm and a ...

Syndax Pharmaceuticals Inc. SNDX) on Monday reported a loss of $60.7 million in its third quarter. The New York-based company said it had a loss of 70 cents per share.